EXOR NV (EXO.AS) Fundamental Analysis & Valuation

AMS:EXO • NL0012059018

Current stock price

68.25 EUR
-0.5 (-0.73%)
Last:

This EXO.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EXO.AS Profitability Analysis

1.1 Basic Checks

  • In the past year EXO has reported negative net income.
  • In the past year EXO had a positive cash flow from operations.
  • Of the past 5 years EXO 4 years were profitable.
  • In the past 5 years EXO always reported a positive cash flow from operatings.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • With a Return On Assets value of -10.22%, EXO is not doing good in the industry: 82.46% of the companies in the same industry are doing better.
  • EXO's Return On Equity of -11.41% is on the low side compared to the rest of the industry. EXO is outperformed by 78.95% of its industry peers.
Industry RankSector Rank
ROA -10.22%
ROE -11.41%
ROIC N/A
ROA(3y)9.59%
ROA(5y)7.14%
ROE(3y)15%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • EXO's Profit Margin has improved in the last couple of years.
  • In the last couple of years the Operating Margin of EXO has grown nicely.
  • The Profit Margin and Operating Margin and Gross Margin are not available for EXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y110.92%
OM growth 5Y65.84%
PM growth 3Y120.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

8

2. EXO.AS Health Analysis

2.1 Basic Checks

  • EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EXO has less shares outstanding
  • EXO has less shares outstanding than it did 5 years ago.
  • EXO has a worse debt/assets ratio than last year.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • EXO has an Altman-Z score of 3.07. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EXO (3.07) is better than 75.44% of its industry peers.
  • EXO has a debt to FCF ratio of 1.28. This is a very positive value and a sign of high solvency as it would only need 1.28 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.28, EXO belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
  • EXO has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of EXO (0.10) is better than 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.28
Altman-Z 3.07
ROIC/WACCN/A
WACC4.67%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • EXO has a Current Ratio of 4.32. This indicates that EXO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.32, EXO belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
  • A Quick Ratio of 4.32 indicates that EXO has no problem at all paying its short term obligations.
  • EXO has a Quick ratio of 4.32. This is amongst the best in the industry. EXO outperforms 84.21% of its industry peers.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 4.32
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

1

3. EXO.AS Growth Analysis

3.1 Past

  • The earnings per share for EXO have decreased strongly by -127.86% in the last year.
  • EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -122.85%.
EPS 1Y (TTM)-127.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13840.41%
Revenue 1Y (TTM)-122.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1261.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 50.19% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by 0.00% on average over the next years.
EPS Next Y81.32%
EPS Next 2Y50.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10 20 30

2

4. EXO.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • EXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EXO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXO indicates a rather cheap valuation: EXO is cheaper than 85.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.95
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • EXO's earnings are expected to grow with 50.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.19%
EPS Next 3YN/A

1

5. EXO.AS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.71%, EXO is not a good candidate for dividend investing.
  • EXO's Dividend Yield is comparable with the industry average which is at 2.39.
  • With a Dividend Yield of 0.71, EXO pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

  • The dividend of EXO decreases each year by -17.34%.
Dividend Growth(5Y)-17.34%
Div Incr Years2
Div Non Decr Years3
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • EXO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-2.45%
EPS Next 2Y50.19%
EPS Next 3YN/A
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

EXO.AS Fundamentals: All Metrics, Ratios and Statistics

EXOR NV

AMS:EXO (4/24/2026, 7:00:00 PM)

68.25

-0.5 (-0.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-23
Earnings (Next)N/A
Inst Owners28.52%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap14.18B
Revenue(TTM)-3.52B
Net Income(TTM)-3.79B
Analysts86.15
Price Target111.56 (63.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend0.45
Dividend Growth(5Y)-17.34%
DP-2.45%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.06%
PT rev (3m)-4.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-193.17%
EPS NY rev (3m)-201.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 4.95
P/OCF 4.95
P/B 0.43
P/tB 0.43
EV/EBITDA N/A
EPS(TTM)-18.63
EYN/A
EPS(NY)-1.98
Fwd EYN/A
FCF(TTM)13.78
FCFY20.19%
OCF(TTM)13.78
OCFY20.19%
SpS-16.93
BVpS159.98
TBVpS159.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -10.22%
ROE -11.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM -81.38%
ROA(3y)9.59%
ROA(5y)7.14%
ROE(3y)15%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y110.92%
OM growth 5Y65.84%
PM growth 3Y120.17%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.09
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.32
Quick Ratio 4.32
Altman-Z 3.07
F-Score5
WACC4.67%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13840.41%
EPS Next Y81.32%
EPS Next 2Y50.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-122.85%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1261.18%
Revenue Next Year0%
Revenue Next 2Y0%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-121.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5991.49%
FCF growth 3Y5.04%
FCF growth 5Y-5.5%
OCF growth 1Y5991.49%
OCF growth 3Y-16.5%
OCF growth 5Y-27.25%

EXOR NV / EXO.AS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of EXOR NV (EXO.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXO.AS.


What is the valuation status for EXO stock?

ChartMill assigns a valuation rating of 2 / 10 to EXOR NV (EXO.AS). This can be considered as Overvalued.


How profitable is EXOR NV (EXO.AS) stock?

EXOR NV (EXO.AS) has a profitability rating of 3 / 10.


What is the earnings growth outlook for EXOR NV?

The Earnings per Share (EPS) of EXOR NV (EXO.AS) is expected to grow by 81.32% in the next year.


Is the dividend of EXOR NV sustainable?

The dividend rating of EXOR NV (EXO.AS) is 1 / 10 and the dividend payout ratio is -2.45%.